Novo Nordisk sued Effinger Health, doing business as Rx Weight Loss Tallahassee Clinic, on Tuesday in Texas Southern District Court over trademark infringement claims. The lawsuit, brought by King & Spalding, centers on Novo Nordisk’s trademarked Wegovy medication for weight management and on a molecule known as semaglutide, which Novo Nordisk has exclusive government authorization to use in drugs. According to the complaint, the defendant uses the Wegovy trademark to market its own drugs and claims that those drugs contain semaglutide. Lawyers have not yet appeared for the defendant. The case is 4:23-cv-00265, Novo Nordisk A/S et al v. Effinger Health PA Tallahassee Clinic.
Biotech & Pharmaceuticals
June 20, 2023, 11:56 AM